Prevalence of sickle cell disease in a pediatric population suffering from severe infections: a Congolese experience

Diane A Kondani1, Jean Lambert Gini-Ehungu, Joseph M Bodi

  • 1Haemato-Oncology and Nephrology Division, Haematology Unit, Department of Paediatrics, University Hospital of Kinshasa, School of Medicine, University of Kinshasa , Kinshasa , Democratic Republic of Congo.

Hemoglobin
|July 16, 2014
PubMed

Insights

In the Democratic Republic of Congo, 7.7% of children with severe infections had sickle cell anemia (Hb SS). Opportunistic screening for sickle cell disease in these children is recommended until universal neonatal screening is established.

Area of Science:

  • Pediatrics
  • Hematology
  • Infectious Diseases

Background:

  • Neonatal screening for sickle cell anemia is uncommon in the Democratic Republic of Congo (DRC).
  • Children with sickle cell disease face a higher risk of severe infections.

Purpose of the Study:

  • To determine the prevalence of sickle cell anemia among children experiencing severe infections in the DRC.
  • To assess the feasibility and value of opportunistic sickle cell anemia testing in this population.

Main Methods:

  • A prospective pilot study was conducted in four public hospitals in Kinshasa, DRC, from July 2009 to July 2011.
  • 247 children with severe infections were recruited and screened for sickle cell disease using a three-stage sampling method.
  • Data on patient demographics, vaccination status, and blood culture results were collected.

Main Results:

  • Among 247 children with severe infections, 19 (7.7%) were diagnosed with homozygous sickle cell anemia (Hb SS).
  • Sickle cell patients exhibited a higher rate of positive blood cultures (15.8%) compared to non-Hb S children (6.1%).
  • Approximately 8.0% of children carried unknown sickle cell anemia mutations.

Conclusions:

  • Opportunistic screening for sickle cell anemia is a viable strategy for children presenting with severe infections in the DRC.
  • This approach can help identify affected individuals until universal neonatal screening becomes standard practice.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
96
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
83